Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Matthew ...

Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most transformative frontiers in oncology and biotechnology. These advanced ...

The Council for Scientific and Industrial Research (CSIR) has assured Ghanaians that Genetically Modified (GM) foods, particularly the Pod Borer Resistant (PBR) cowpea, were safe, nutritious, and ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced ...

The revenue generated by DNA polymerase in 2024 was USD 374.8 million. The surge in genetic disorders such as cystic fibrosis ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.